Does RETIFANLIMAB Cause Pulmonary embolism? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Pulmonary embolism have been filed in association with RETIFANLIMAB (ZYNYZ). This represents 9.4% of all adverse event reports for RETIFANLIMAB.
9
Reports of Pulmonary embolism with RETIFANLIMAB
9.4%
of all RETIFANLIMAB reports
2
Deaths
9
Hospitalizations
How Dangerous Is Pulmonary embolism From RETIFANLIMAB?
Of the 9 reports, 2 (22.2%) resulted in death, 9 (100.0%) required hospitalization, and 7 (77.8%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for RETIFANLIMAB.
What Other Side Effects Does RETIFANLIMAB Cause?
Diarrhoea (23)
Nausea (14)
Neutrophil count decreased (12)
White blood cell count decreased (12)
Disease progression (11)
Neutropenic sepsis (11)
Condition aggravated (9)
Pyrexia (9)
Asthenia (8)
Blood sodium decreased (8)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)